Teen Depressive Symptoms Can Persist Into Young Adulthood
By Lori Solomon HealthDay Reporter
TUESDAY, Aug. 20, 2024 -- Increases in depressive symptoms in adolescence can persist into young adulthood for people born from 1997 to 2001, with higher rates of depressive symptoms than previous birth cohorts, according to a study published online Aug. 14 in JAMA Network Open.
Katherine M. Keyes, Ph.D., from the Mailman School of Public Health at Columbia University in New York City, and colleagues assessed the extent to which increases in adolescent depressive symptoms in recent birth cohorts persists among young adults. The analysis included data from 36,552 participants in the Monitoring the Future longitudinal survey from 1990 to 2019 for birth cohorts from 1972 to 2001.
The researchers found that among females, 19.1 percent of the 1997 to 2001 birth cohort had high depressive symptoms at age 18 years, higher than any previous birth cohort. Depressive symptom prevalence declined by age 21 to 22 years but still remained higher than prevalence among previous cohorts at that age. Among males, 13.4 percent of the 1997 to 2001 birth cohort had high depressive symptoms at age 18 years, with prevalence increasing through young adulthood. For males with high baseline depressive symptoms, the odds of symptoms at age 19 to 20 years were 10-fold higher and sixfold higher for symptoms at age 21 to 22 years. Similar findings were seen for females, with ninefold higher odds of symptoms at age 19 to 20 years and sevenfold higher odds of symptoms at age 21 to 22 years.
"Findings of this study suggest the need for primary prevention and mental health resources during the adolescent years," the authors write.
One author reported receiving personal fees from the law firms Lieff Cabraser and Motley Rice.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted August 2024
Read this next
Psilocybin Plus Psychotherapy Offers Lasting Benefit in Cancer, Depression
MONDAY, June 16, 2025 -- For cancer patients with a major depressive disorder, a single dose of psilocybin combined with psychological support can provide sustained relief for...
Shorter Leukocyte Telomere Length Linked to Higher Incidence of Age-Related Brain Diseases
THURSDAY, June 12, 2025 -- Individuals with shorter leukocyte telomere length (LTL) have a higher incidence of stroke, dementia, and late-life depression (LLD), individually and...
Talking Therapy Reduces Depression, Anxiety Symptoms in Stroke Survivors
THURSDAY, June 12, 2025 -- For stroke survivors, talking therapy is associated with moderate reductions in depression and large reductions in anxiety symptoms, according to a...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.